Abstracts
Showing 852 abstracts.
Citation
Shaffiq M. Essajee, Ram Yogev, M.D., Henry Pollack, M.D., B. Greenhouse, Keith Krasinski, M.D., William Borkowsky, M.D. Viral Genotypic Responses to Recombinant Vaccine Therapy in HIV-1 Infected Children.Citation
Sandra K. Burchett, M.D., M.S., Margaret Khoury, M.D., Kenneth McIntosh, M.D., S. V. Carey, Rebecca Oyomopito, M.S., Lynne M. Mofenson, M.D., F.A.A.P., Elizabeth (Betsy) Smith, M.D., Andrea Kovacs, M.D. Viral Load Reduction (VLR) In HIV-Infected Children With Advanced Disease Treated With 4-Drug ARV Regimens Including NRTIs, Nevirapine (NVP), Nelfinavir (NFV), and/or Ritonavir (RTV).Citation
G. M. Ellis, William Borkowsky, M.D., Ram Yogev, M.D., Bonnie J. Ank, Petronella Muresan, M.S., Terence Fenton, Ed.D., Barbara E. Heckman, B.S., Elizabeth (Betsy) J. McFarland, M.D., Edmund Capparelli, Pharm.D., John ( Jack ) Moye, Jr., M.D., Shirley Jankelevich, M.D., Lisa M. Frenkel, M.D. Viral populations with distinct drug-resistant genotypes shift during repeated STI.Study
P1015
Citation
Sandra K. Burchett, M.D., M.S., Vincent J. Carey, Ph.D., Florence H. Yong, M.S., John L. Sullivan, M.D., Steven Sulzbacher, Ph.D., Lucy Civitello, M.D., Mary Culnane, C.R.N.P., M.S., Lynne M. Mofenson, M.D., F.A.A.P., Suzanne Siminski, M.S., M.B.A., Patrick Robinson, M.D., Katherine Luzuriaga, M.D. Virologic Activity Of Didanosine (DDL), Zidovudine (ZDV) and Nevirapine (NVP) Combinations In Pediatric Subjects With Advanced Disease.Citation
Ram Yogev, M.D., William Borkowsky, M.D., Petronella Muresan, M.S., Terence Fenton, Ed.D., Elizabeth (Betsy) J. McFarland, M.D., Lisa M. Frenkel, M.D., Edmund Capparelli, Pharm.D., Barbara E. Heckman, B.S., John ( Jack ) Moye, Jr., M.D., Shirley Jankelevich, M.D. Virologic and Clinical Outcomes of a Progressively Increasing Structured Treatment Interruption Study in Chronically-infected Children.Study
P1015
Citation
Adriana Weinberg, M.D., Paula Britto, M.S., ChengCheng Hu, Ph.D., Ruth E. Dickover, Ph.D., Mobeen H. Rathore, M.D., Ross E. McKinney, Jr., M.D. Virologic and immunologic correlates of immune reconstitution in HIV-infected children on FTC/DDI/EFV: PACTG protocol P1021. Presented at: 13th Conference on Retroviruses and Opportunistic Infections.Conference
13th Conference on Retroviruses and Opportunistic Infections
Study
P1021
Citation
Virologic and immunologic outcomes and adherence in adolescents initiating HAART: 3-year follow-up data from PACTG 381. Presented at: 13th Conference on Retroviruses and Opportunistic Infections.Conference
13th Conference on Retroviruses and Opportunistic Infections
Citation
Andrea Kovacs, M.D., Sandra K. Burchett, M.D., M.S., Margaret Khoury, M.D., Vincent J. Carey, Ph.D., Savita G. Pahwa, M.D., Kenneth McIntosh, M.D., Rebecca Oyomopito, M.S., Elizabeth (Betsy) Smith, M.D., Lynne M. Mofenson, M.D., F.A.A.P. Virologic and immunologic responses in children with advanced HIV disease on a new HAART regimen (PACTG 366). Presented at: 8th Conference on Retroviruses & Opportunistic Infections.Conference
8th Conference on Retroviruses & Opportunistic Infections